EVOLVE

Serial Number 90062393
Registration 6631214
700

Registration Progress

Application Filed
Jul 20, 2020
Under Examination
Approved for Publication
Nov 16, 2021
Published for Opposition
Nov 16, 2021
Registered
Feb 1, 2022

Trademark Image

EVOLVE

Basic Information

Serial Number
90062393
Registration Number
6631214
Filing Date
July 20, 2020
Registration Date
February 1, 2022
Published for Opposition
November 16, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 1, 2022
Registration
Registered
Classes
042

Rights Holder

Intellihealth, Inc.

03
Address
655 Montgomery Street
San Francisco, CA 94111

Ownership History

Intellihealth, Inc.

Original Applicant
03
San Francisco, CA

Intellihealth, Inc.

Owner at Publication
03
San Francisco, CA

Intellihealth, Inc.

Original Registrant
03
San Francisco, CA

Legal Representation

Attorney
JEFFERSON F. SCHER

USPTO Deadlines

Next Deadline
813 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-02-01)
Due Date
February 01, 2028
Grace Period Ends
August 01, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Feb 1, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 16, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 27, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 14, 2021 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 14, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 10, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 1, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 1, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 31, 2021 ALIE A ASSIGNED TO LIE Loading...
Aug 26, 2021 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Aug 26, 2021 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Aug 26, 2021 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Aug 26, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Feb 26, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 26, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 26, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 5, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 4, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 6, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 6, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 6, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 3, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 23, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Software as a service (SAAS) services featuring software for use by health care providers in implementing, managing, and monitoring pharmacotherapy and behavior modification programs for the prevention and treatment of obesity and obesity-linked diseases and conditions; Software as a service (SAAS) services featuring software for use by employers in implementing, managing, and monitoring employee benefit programs directed toward the prevention and treatment of obesity and obesity-linked diseases and conditions; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions through identification, assessment and diagnosis of patients for the development of individual treatment plans, goals, and recommendations; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions through collecting, logging, tracking, analyzing, managing, and reporting test results, activity data, and other health indications; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions providing clinical decision support and clinical outcome analytics; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions through facilitation of provider-patient communications on goal setting, individual progress and plan adjustments; Software as a service (SAAS) services featuring software for use in the prevention and treatment of obesity and obesity-linked diseases and conditions providing remote patient monitoring
First Use Anywhere: Apr 24, 2020
First Use in Commerce: Apr 24, 2020

Classification

International Classes
042